Search Contract Opportunities

10X Genomics, Inc Chromium instrument.

ID: 25-003973 • Type: Presolicitation
Question & Answer Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Please sign-in to link federal registration and award history to assistant. Sign in to upload a capability statement or catalogue for your company

Some suggestions:
Please summarize the work to be completed under this opportunity
Draft a response outline indicating that my company is also capable of performing this sole source work
Do the documents mention an incumbent contractor?
I'd like to anonymously submit a question to the procurement officer(s)
Loading

Description

Title: 10X Genomics, Inc Chromium instrument.

  • Product Service Code: 6640 - Laboratory Equipment and Supplies
  • NAICS Code: 334516 - Analytical Laboratory Instrument Manufacturing
  • Place of Performance: Bethesda, MD 20892

POTS: 25-003973

Description

This is a notice of intent, not a request for a quotation. A solicitation document will not be issued, and quotations will not be requested.

The National Institutes of Health, Clinical Center, Office of Purchasing and Contracts on behalf of the Department of Laboratory Medicine intends to award a firm-fixed priced sole source basis for the procurement of the following items listed below from 10X Genomics, Inc.

List of Equipment:

Qty

(1) Chromium X & Accessory Kit (1)

(2) Dual Index Kit TS Set A, 96 rxn (1)

(3) GEM-X Flex Gene Expression Chip Kit, 4 chips (2)

(4) GEM-X Flex Sample Preparation v2 Kit, 48 rxns (1)

(5) GEM-X Flex Gene Expression Human, 4 samples (12)

(6) Shipping and Handling

10X Genomics is the original equipment manufacturer. 10X Genomics Chromium instrument is used to perform single cell gene expression experiment by analyzing mRNA level in single cells derived from patient blood and bone marrow samples. The Chromium allows study of gene expression at the single cell level. 10X Genomics manufacturing operations are regulated by the Current Good Manufacturing Practices (cGMPs) as mandated by the Food and Drug Administration. This equipment is used to grow primary cellular material as part of the manufacturing process. The device is highly specialized. Genomics Chromium Instrument determine gene expression on single cells isolated from patient blood and bone marrow specimens and is recommended and validated for Department of Laboratory Medicine quality-controlled processes. To use another, make or model will result in an extensive revalidation of testing procedures which would attract cost for the government.

This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements.

Interested Parties:

Interested parties capable of providing the same or similar products or services described in this notice may submit a capability statement outlining their capability to perform the described work. Capability Statements must be received within the time set forth in this synopsis to be considered by the Government. The determination to compete this proposed contract based on responses to this notice is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement.

Comments:

Comments to this announcement, referencing this posting number, may be submitted to the CC, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, electronically to the attention of Emeka Onyejekwe, Contract Specialist, Emeka.onyejekwe@nih.gov by the due date March, 22th 2025 by Noon (12:00 pm EST) and time marked in this notice.

Overview

Response Deadline
March 22, 2025, 12:00 p.m. EDT Past Due
Posted
March 12, 2025, 9:37 a.m. EDT
Set Aside
None
Place of Performance
Bethesda, MD 20892 United States
Source
SAM

Current SBA Size Standard
1000 Employees
Pricing
Fixed Price
Est. Level of Competition
Sole Source
Est. Value Range
Experimental
<$250,000 (solicitation indicates Simplified Acquisition Procedures, which in most cases, applies to contracts expected to be less than $250K in value)
Odds of Award
42%
On 3/12/25 NIH Clinical Center issued Presolicitation 25-003973 for 10X Genomics, Inc Chromium instrument. due 3/22/25. The opportunity was issued full & open with NAICS 334516 and PSC 6640.
Primary Contact
Name
Emeka Onyejekwe   Profile
Phone
(000) 000-0000

Documents

Posted documents for Presolicitation 25-003973

Question & Answer

Incumbent or Similar Awards

Contracts Similar to Presolicitation 25-003973

Potential Bidders and Partners

Awardees that have won contracts similar to Presolicitation 25-003973

Similar Active Opportunities

Open contract opportunities similar to Presolicitation 25-003973

Additional Details

Source Agency Hierarchy
HEALTH AND HUMAN SERVICES, DEPARTMENT OF > NATIONAL INSTITUTES OF HEALTH > NATIONAL INSTITUTES OF HEALTH - CC
FPDS Organization Code
7529-75N900
Source Organization Code
100189036
Last Updated
April 7, 2025
Last Updated By
emeka.onyejekwe@nih.gov
Archive Date
April 6, 2025